Axsome Therapeutics (AXSM) PT Raised to $275 at TD Cowen

May 4, 2026 12:06 PM

TD Cowen analyst Joseph Thome raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $275.00 (from $255.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found